6/30/04
Accelerator Corporation—Carl Weissman
VieVax Corporation—Dr. Gregory G.
Mahairas
VLST Corporation—Dr. Craig A. Smith and
Dr. Steven R. Wiley

Dr. Fraser Stoddart and Dr. Evelyn Hu—
California NanoSystems Institute
John Paul—Finnegan Henderson

6/23/04
Caliper Life Sciences
Entelos, Inc.
BioniCare

6/16/04
The Honorable Phillip J. Bond, Under
Secretary of Commerce for Technology
Dr. Samuel I. Doctors, Advancing
California's EmergingTechnologies (ACET)
Brent Erickson, Vice President, Industrial
and Environmental Section, BIO
Lewis S. Gruber, Arryx, Inc.

6/2/04
CzechInvest and IQA
Texas Healthcare and Bioscience Institute,
and INCELL Corporation
Dr. Michael Liebman—The Windber
Research Institute

5/26/04
Dr. Ken Chien—UCSD Institute of Molecular
Medicine
Dr. Jun Wu—Shanghai Genomics, Inc.
Dr. Michael Heller—Nanogen, Inc.

5/19/04
Lowenstein Sandler
Clemson University
Michael Werner—Chief of Policy, BIO

5/12/04
Dr. James Crutchfield and Dr. David
Krakauer—Santa Fe Institute
Modular Genetics, Inc.
Bone Tissue Engineering Center—
Carnegie Mellon University

5/5/04
SynCardia Systems
Organ Recovery Systems
NovaVision

4/28/04
U.S. Genomics
QIAGEN, Inc.
Cerylid Biosciences Limited

4/21/04
Pam Sobotka—Event Director, 13th Annual
Partnerships™ with CROs
Dr. James Bannon—Covance
Dr. Samuel Barnett—IBM Business
Consulting Services
Jonathan Koch—Inveresk
Dr. Chris Gallen—Wyeth
James Powers—PRA International

Dr. Homer Pearce—Eli Lilly and Company
Dr. David Bishop and Dr. Susanne Arney—
Bell Labs, Lucent Technologies
Dr. Sharon Wampler—UCSD Extension
Bioscience

4/14/04
Philip J. Kuekes—Hewlett-Packard
Laboratories
Novavax, Inc.
NanoOpto Corporation

4/7/04
Nanosphere, Inc.
Cubist Pharmaceuticals
Applied Nanotech, Inc.

3/31/04
Dr. Philip Campbell—Editor-in-Chief, Nature
NanoString Technologies
Regeneration Technologies, Inc.

3/24/04
Dr. Craig Prater—Veeco Instruments Inc.
Dr. Carlo Montemagno—UCLA's Biomedical
Engineering IDP
Dr. Ping Sheng—Institute of
Nano Science and Technology, Hong Kong
University of Science and Technology

3/22/04
Ms. Barbara Yanni—Merck & Co.
Mr. Dennis Purcell—Perseus-Soros
BioPharmaceutical Fund
Dr. Abbie Celniker—Millennium
Pharmaceuticals, Inc.

3/17/04
The Honorable Phillip J. Bond, Under
Secretary of Commerce for Technology
Dr. Mark Ratner—Northwestern University
Dr. Meyya Meyyappan—NASA Ames
Research Center

3/10/04
Tulane University Health Sciences Center,
Tulane Center for Gene Therapy, and
Tulane National Primate Research Center
Dr. Paul Whelton
Dr. Darwin Prockop
Dr. Preston Marx

3/3/04
Dr. Mike Roco—Senior Advisor for
Nanotechnology, National Science
Foundation
Dr. Carlo Montemagno—Chairman of UCLA’s Department of Bioengineering
Dr. James Canton—Institute for Global
Futures
Dr. David Carroll—The Center for
Nanotechnology at Wake Forest
University
Mr. Richard Shanley—Deloitte & Touche LLP
Ms. Sonia Miller—Converging Technologies
Bar Association

2/25/04
Institute for Systems Biology
Pacific Northwest National Laboratory
Washington Biotechnology & Biomedical
Association

2/23/04
Duke Clinical Research Institute
Genzyme Corporation
Rebroadcast of 12/10/03 Special Research
Roundtable (Part 1) with Dr. Andrew Fire,
Dr. Alejandro Sánchez Alvarado, and
Dr. John Mattick

2/18/04
Dr. Richard Cummings—Oklahoma Center
for Medical Glycobiology
InterGenetics Incorporated
Presbyterian Health Foundation

2/11/04
Audubon Center for Research of
Endangered Species
ReliaGene Technologies, Inc.
College of Pharmacy at Xavier University
of Louisiana

2/4/04
BIOCOM
California State University Program for
Education and Research in Biotechnology
Dow Plant Biopharmaceuticals—
The Dow Chemical Company

1/28/04
Isis Pharmaceuticals, Inc.
Entrepreneurial Management Center at
San Diego State University
GeneGo, Inc.

1/21/04
Ms. Kim Cauthorn—Marsh Risk Consulting
Ms. Kathy Waller—Financial Relations
Board
Skyscape

1/19/04
Drug Delivery Partnerships Conference
Hamilton Apex Technology Ventures
PharmaCircle
West Drug Delivery, West Pharmaceutical
Services
Aradigm
Honeywell Specialty Films

1/14/04
NanoInk, Inc.
Antisense Therapeutics Limited
Ms. Maria Sendra—Clifford Chance

1/7/04
Mr. Kitu Bindra—Burns Doane
TBN Bioscience Initiative/Medical Carbon
Research Institute
Caprion Pharmaceuticals

12/23/03
Vanderbilt Institute for Nanoscale Science
and Engineering
TransTech Pharma
Eli Lilly and Company—Department of
Women's Health and Reproductive
Medicine

12/17/03
Illinois Biotechnology Industry
Organization
AusAm Biotechnologies, Inc.
EraGen Biosciences

12/10/03
Special research roundtable on RNA
interference, regeneration and gene
expression, and non-protein-coding RNAs. With Dr. Andrew Fire, Dr. Alejandro
Sánchez Alvarado, and Dr. John Mattick

Diversa Corporation

12/3/03
Kucera Pharmaceutical Company
U.S. Genomics
Veeco

11/26/03
Oncolytics Biotech, Inc.
Ambion, Inc.
Worcester Polytechnic Institute
Bioengineering Institute

11/19/03
BC Biotech
Prof. Mark Ratner—Nanotechnology and
Homeland Security: New Weapons for
New Wars
Omeris

11/12/03
ITI Scotland and Scottish Development
International
Biomega Laboratories
Simon Fraser University—Management of
Technology MBA

11/5/03
Cepheid
San Diego Regional Technology Alliance
Dr. Shannon Mrksich—Brinks Hofer Gilson
& Lione

Contact Information
Dr. David Lemberg
619-540-9038
Email Dr. David Lemberg

Sam Kephart
605-717-6100
Email Sam Kephart

TOP

Welcome to "Science and Society"

"SCIENCE AND SOCIETY" Manifesto: "Science and Society" is broadly focused on nanotechnology, life sciences, space exploration, planetary science, K-12 science education, and the intersection between science and art. Over the last several years we have interviewed more than 350 trendsetting and groundbreaking reseachers, industry-leading executives, and senior government officials.

"Science and Society" began life in June 2003 as "BioTech Today", Internet talk radio focusing on biotechnology and related industries. Early on, the content of "BioTech Today" expanded far beyond these boundaries. A new title was needed, matching the show's mission and message. Thus, "Science and Society" was born. The show provides a supportive conversational environment, allowing guests to present their mission and message to a wide-ranging and inclusive international audience. "Science and Society" participates in the process of strengthening the links between science and society, helping to improve daily living, health, and well-being for all of us for decades to come.

Dr. David Lemberg is a broadcaster and media consultant with a formal background in biochemistry research. Before relocating to San Diego, David practiced chiropractic in Manhattan for more than 20 years. A popular guest and speaker, David's television appearances include spots on "WABC Sunday Eyewitness News" and "Good Day, New York". Recently David was Moderator/MC for the Oklahoma BioLife Science Symposium, in Oklahoma City. In April 2005 he moderated the Boston conference, "The Health of Nations: Scotland and America Life Science Partnerships".

Sam Kephart is President and CEO of Virtual Acumen, a digital media developer, e-learning, and creative production firm, based in Spearfish, SD. Sam has hosted and/or produced more than 250 television and digital media projects for a wide range of clients. Sam has been an award-winning salesman with over 30 years experience in direct sales, sales training, sales management and marketing, with a special emphasis in dealing with senior level executives, dealer networks, and independent entrepreneurs.TOP

Copyright © 2004 Tipping Point Productions. All rights reserved